158 related articles for article (PubMed ID: 15838301)
1. The peroxisome proliferator-activated receptor alpha activator fenofibrate inhibits endothelin-1-induced cardiac fibroblast proliferation.
Ogata T; Miyauchi T; Irukayama-Tomobe Y; Takanashi M; Goto K; Yamaguchi I
J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S279-82. PubMed ID: 15838301
[TBL] [Abstract][Full Text] [Related]
2. Endothelin-1-induced cardiac hypertrophy is inhibited by activation of peroxisome proliferator-activated receptor-alpha partly via blockade of c-Jun NH2-terminal kinase pathway.
Irukayama-Tomobe Y; Miyauchi T; Sakai S; Kasuya Y; Ogata T; Takanashi M; Iemitsu M; Sudo T; Goto K; Yamaguchi I
Circulation; 2004 Feb; 109(7):904-10. PubMed ID: 14967736
[TBL] [Abstract][Full Text] [Related]
3. Endothelin-1-Induced Cell Hypertrophy in Cardiomyocytes is Improved by Fenofibrate: Possible Roles of Adiponectin.
Jen HL; Yin WH; Chen JW; Lin SJ
J Atheroscler Thromb; 2017 May; 24(5):508-517. PubMed ID: 27629528
[TBL] [Abstract][Full Text] [Related]
4. Activation of peroxisome proliferator-activated receptor-alpha decreases endothelin-1-induced p38 mitogen-activated protein kinase activation in cardiomyocytes.
Irukayama-Tomobe Y; Miyauchi T; Kasuya Y; Sakai S; Goto K; Yamaguchi I
J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S358-61. PubMed ID: 15838320
[TBL] [Abstract][Full Text] [Related]
5. Effects and mechanisms of PPARalpha activator fenofibrate on myocardial remodelling in hypertension.
Li CB; Li XX; Chen YG; Zhang C; Zhang MX; Zhao XQ; Hao MX; Hou XY; Gong ML; Zhao YX; Bu PL; Zhang Y
J Cell Mol Med; 2009; 13(11-12):4444-52. PubMed ID: 18754816
[TBL] [Abstract][Full Text] [Related]
6. Activation of PPAR alpha by fenofibrate inhibits apoptosis in vascular adventitial fibroblasts partly through SIRT1-mediated deacetylation of FoxO1.
Wang WR; Liu EQ; Zhang JY; Li YX; Yang XF; He YH; Zhang W; Jing T; Lin R
Exp Cell Res; 2015 Oct; 338(1):54-63. PubMed ID: 26226216
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of NF-kappaB signaling by fenofibrate, a peroxisome proliferator-activated receptor-alpha ligand, presents a therapeutic strategy for rheumatoid arthritis.
Okamoto H; Iwamoto T; Kotake S; Momohara S; Yamanaka H; Kamatani N
Clin Exp Rheumatol; 2005; 23(3):323-30. PubMed ID: 15971419
[TBL] [Abstract][Full Text] [Related]
8. Peroxisome proliferator-activated receptor alpha-independent actions of fenofibrate exacerbates left ventricular dilation and fibrosis in chronic pressure overload.
Duhaney TA; Cui L; Rude MK; Lebrasseur NK; Ngoy S; De Silva DS; Siwik DA; Liao R; Sam F
Hypertension; 2007 May; 49(5):1084-94. PubMed ID: 17353509
[TBL] [Abstract][Full Text] [Related]
9. Differential effects on lung cancer cell proliferation by agonists of glucocorticoid and PPARα receptors.
Liang H; Kowalczyk P; Junco JJ; Klug-De Santiago HL; Malik G; Wei SJ; Slaga TJ
Mol Carcinog; 2014 Sep; 53(9):753-63. PubMed ID: 23625588
[TBL] [Abstract][Full Text] [Related]
10. Fenofibrate inhibits endothelin-1 expression by peroxisome proliferator-activated receptor α-dependent and independent mechanisms in human endothelial cells.
Glineur C; Gross B; Neve B; Rommens C; Chew GT; Martin-Nizard F; Rodríguez-Pascual F; Lamas S; Watts GF; Staels B
Arterioscler Thromb Vasc Biol; 2013 Mar; 33(3):621-8. PubMed ID: 23329136
[TBL] [Abstract][Full Text] [Related]
11. Treatment of experimental autoimmune uveoretinitis with peroxisome proliferator-activated receptor α agonist fenofibrate.
Osada M; Sakai T; Kuroyanagi K; Kohno H; Tsuneoka H
Mol Vis; 2014; 20():1518-26. PubMed ID: 25489225
[TBL] [Abstract][Full Text] [Related]
12. PPAR-γ activation by rosiglitazone suppresses angiotensin II-mediated proliferation and phenotypictransition in cardiac fibroblasts via inhibition of activation of activator protein 1.
Hou X; Zhang Y; Shen YH; Liu T; Song S; Cui L; Bu P
Eur J Pharmacol; 2013 Sep; 715(1-3):196-203. PubMed ID: 23791613
[TBL] [Abstract][Full Text] [Related]
13. Peroxisome proliferator-activated receptor α (PPARα) contributes to control of melanogenesis in B16 F10 melanoma cells.
Grabacka M; Wieczorek J; Michalczyk-Wetula D; Malinowski M; Wolan N; Wojcik K; Plonka PM
Arch Dermatol Res; 2017 Apr; 309(3):141-157. PubMed ID: 28084540
[TBL] [Abstract][Full Text] [Related]
14. Fenofibrate induced PPAR alpha expression was attenuated by oestrogen receptor alpha overexpression in Hep3B cells.
Jeng LB; Velmurugan BK; Hsu HH; Wen SY; Shen CY; Lin CH; Lin YM; Chen RJ; Kuo WW; Huang CY
Environ Toxicol; 2018 Feb; 33(2):234-247. PubMed ID: 29134746
[TBL] [Abstract][Full Text] [Related]
15. Stimulation of peroxisome-proliferator-activated receptor alpha (PPAR alpha) attenuates cardiac fibrosis and endothelin-1 production in pressure-overloaded rat hearts.
Ogata T; Miyauchi T; Sakai S; Irukayama-Tomobe Y; Goto K; Yamaguchi I
Clin Sci (Lond); 2002 Aug; 103 Suppl 48():284S-288S. PubMed ID: 12193105
[TBL] [Abstract][Full Text] [Related]
16. Peroxisome proliferator-activated receptor activators inhibit thrombin-induced endothelin-1 production in human vascular endothelial cells by inhibiting the activator protein-1 signaling pathway.
Delerive P; Martin-Nizard F; Chinetti G; Trottein F; Fruchart JC; Najib J; Duriez P; Staels B
Circ Res; 1999 Sep; 85(5):394-402. PubMed ID: 10473669
[TBL] [Abstract][Full Text] [Related]
17. Peroxisome proliferator-activated receptor alpha agonist-induced down-regulation of hepatic glucocorticoid receptor expression in SD rats.
Chen X; Li M; Sun W; Bi Y; Cai M; Liang H; Yu Q; He X; Weng J
Biochem Biophys Res Commun; 2008 Apr; 368(4):865-70. PubMed ID: 18267115
[TBL] [Abstract][Full Text] [Related]
18. Peroxisome Proliferator-Activated Receptor
Jen HL; Liu PL; Chen YH; Yin WH; Chen JW; Lin SJ
Mediators Inflamm; 2016; 2016():5609121. PubMed ID: 27807394
[TBL] [Abstract][Full Text] [Related]
19. PPARα activation inhibits endothelin-1-induced cardiomyocyte hypertrophy by prevention of NFATc4 binding to GATA-4.
Le K; Li R; Xu S; Wu X; Huang H; Bao Y; Cai Y; Lan T; Moss J; Li C; Zou J; Shen X; Liu P
Arch Biochem Biophys; 2012 Feb; 518(1):71-8. PubMed ID: 22198280
[TBL] [Abstract][Full Text] [Related]
20. Fenofibrate ameliorates cardiac hypertrophy by activation of peroxisome proliferator-activated receptor-α partly via preventing p65-NFκB binding to NFATc4.
Zou J; Le K; Xu S; Chen J; Liu Z; Chao X; Geng B; Luo J; Zeng S; Ye J; Liu P
Mol Cell Endocrinol; 2013 May; 370(1-2):103-12. PubMed ID: 23518069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
